<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04008589</url>
  </required_header>
  <id_info>
    <org_study_id>REVIS</org_study_id>
    <nct_id>NCT04008589</nct_id>
  </id_info>
  <brief_title>Non-invasive Current Stimulation for Restoration of Vision</brief_title>
  <official_title>Non-invasive Current Stimulation for Restoration of Vision (REVIS) After Unilateral Occipital Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Magdeburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ERA-NET</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Magdeburg</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate effects of current stimulation of the brain on vision
      parameters, vision-related quality of life, and physiological parameters that allow
      concluding about the mechanisms of vision restoration. These include EEG-spectra and
      coherence measures, and visual evoked potentials. The design of stimulation protocols
      involves an appropriate sham-stimulation condition and sufficient follow-up periods to test
      whether the effects are stable. This is the first application of non-invasive current
      stimulation for vision rehabilitation in stroke-related visual field deficits.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2014</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Size of the visual field</measure>
    <time_frame>2 weeks</time_frame>
    <description>Mean threshold in standard static perimetry and and detection accuracy in HRP</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resting EEG power spectra</measure>
    <time_frame>2 weeks</time_frame>
    <description>EEG measurement using 128 channel</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Stroke</condition>
  <condition>Electrical Stimulation</condition>
  <arm_group>
    <arm_group_label>rtACS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>repetitive transorbital ACS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tDCS/rtACS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sequential tDCS - tACS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>repetitive transorbital AC Stimulation</intervention_name>
    <description>Repetitive transorbital ACS with max 30 Hz, 1,5 mA for 10 days, 20 min/day</description>
    <arm_group_label>Sham stimulation</arm_group_label>
    <arm_group_label>rtACS</arm_group_label>
    <arm_group_label>tDCS/rtACS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>combination of transcranial direct current stimulaton and rtACS</intervention_name>
    <description>Sequential tDCS (anodal occipital stimulation with 2 mA for 20 min/day for 10 days) and rtACS</description>
    <arm_group_label>Sham stimulation</arm_group_label>
    <arm_group_label>rtACS</arm_group_label>
    <arm_group_label>tDCS/rtACS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HH due to ischemic or hemorrhagic stroke

          -  age between 18 and 75 years

          -  lesion age at least 6 months

          -  stable visual field defect across baseline measurement (subjects with spontaneous
             fluctuations and recovery of vision excluded)

          -  presence of residual vision and detectable gradual transition between the intact and
             the absolutely blind part of the visual field according to evaluation of the clinician

          -  best corrected visual acuity at least 0.4 (20/50 Snellen) or better

        Exclusion Criteria:

          -  known active malignancy

          -  eye or central nervous system diseases that interfere with the study (including poorly
             controlled glaucoma)

          -  electric or electronic implants (e.g. heart pacemaker)

          -  metal artifacts in the eyes or head (with the exception of dental prosthesis or
             shunts)

          -  expected low compliance (e.g. in case of known psychiatric disease, known drug abuse,
             and dementing syndromes)

          -  epileptic seizure within the last 10 years

          -  use of antiepileptic or sedative drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute of Medical Psychology</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 3, 2019</study_first_submitted>
  <study_first_submitted_qc>July 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>July 3, 2019</last_update_submitted>
  <last_update_submitted_qc>July 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Magdeburg</investigator_affiliation>
    <investigator_full_name>Bernhard A. Sabel</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Research data will be avalaible without restriction</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>After the publication of the data</ipd_time_frame>
    <ipd_access_criteria>Contact to the PI</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

